Regulation of interferon lambda-1 (IFNL1/IFN-λ1/IL-29) expression in human colon epithelial cells

Cytokine

Volumn 65, Issue 1, 2014, Pages 17-23

  Swider, Adam ^a   Siegel, Rachael ^a   Eskdale, Joyce ^a   Gallagher, Grant ^a  

^a HUMIGEN LLC   (United States)

Author keywords

BLIMP 1; IFN 1; IFNL1; IL 29; ZEB1

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BETA INTERFERON; INTERLEUKIN 29; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN P50; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR ZEB1;

ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

BLIMP-1; IFN-Λ1; IFNL1; IL-29; ZEB1;

2',5'-OLIGOADENYLATE SYNTHETASE; CELL LINE, TUMOR; COLON; EPITHELIAL CELLS; HOMEODOMAIN PROTEINS; HT29 CELLS; HUMANS; INTERLEUKINS; NF-KAPPA B P50 SUBUNIT; POLY I-C; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 3; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS;

EID: 84888204679     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.09.020     Document Type: Article

References (46)

1. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003, 4:69-77.
2. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003, 4:63-68.
3. Gallagher G., Megjugorac N.J., Yu R.Y., Eskdale J., Gallagher G.E., Siegel R., et al. The lambda interferons: guardians of the immune-epithelial interface and the T-helper 2 response. J Interferon Cytokine Res 2010, 30:603-615.
4. Witte K., Witte E., Sabat R., Wolk K. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev 2010, 21:237-251.
5. Prokunina-Olsson L., Muchmore B., Tang W., Pfeiffer R.M., Park H., Dickensheets H., et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 2013, 45:164-171.
6. Coccia E.M., Severa M., Giacomini E., Monneron D., Remoli M.E., Julkunen I., et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004, 34:796-805.
7. Pekarek V., Srinivas S., Eskdale J., Gallagher G. Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. Genes Immun 2007, 8:177-180.
8. Jordan W.J., Eskdale J., Boniotto M., Rodia M., Kellner D., Gallagher G. Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29). Genes Immun 2007, 8:13-20.
9. Jordan W.J., Eskdale J., Srinivas S., Pekarek V., Kelner D., Rodia M., et al. Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Genes Immun 2007, 8:254-261.
10. Sommereyns C., Paul S., Staeheli P., Michiels T. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 2008, 4:e1000017.
11. Srinivas S., Dai J., Eskdale J., Gallagher G.E., Megjugorac N.J., Gallagher G. Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology 2008, 125:492-502.
12. Dai J., Megjugorac N.J., Gallagher G.E., Yu R.Y., Gallagher G. IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells. Blood 2009, 113:5829-5838.
13. Megjugorac N.J., Gallagher G.E., Gallagher G. Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29). J Leukoc Biol 2009, 86:1359-1363.
14. Pulverer J.E., Rand U., Lienenklaus S., Kugel D., Zietara N., Kochs G., et al. Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol 2010, 84:8626-8638.
15. Megjugorac N.J., Gallagher G.E., Gallagher G. IL-4 enhances IFN-lambda1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra. Blood 2010, 115:4185-4190.
16. Yin Z., Dai J., Deng J., Sheikh F., Natalia M., Shih T., et al. Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol 2012, 189:2735-2745.
17. Onoguchi K., Yoneyama M., Takemura A., Akira S., Taniguchi T., Namiki H., et al. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 2007, 282:7576-7581.
18. Osterlund P.I., Pietila T.E., Veckman V., Kotenko S.V., Julkunen I. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol 2007, 179:3434-3442.
19. Marie I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998, 17:6660-6669.
20. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 1998, 441:106-110.
21. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000, 13:539-548.
22. Thomson S.J., Goh F.G., Banks H., Krausgruber T., Kotenko S.V., Foxwell B.M., et al. The role of transposable elements in the regulation of IFN-lambda1 gene expression. Proc Natl Acad Sci USA 2009, 106:11564-11569.
23. Siegel R., Eskdale J., Gallagher G. Regulation of IFN-lambda1 promoter activity (IFN-lambda1/IL-29) in human airway epithelial cells. J Immunol 2011, 187:5636-5644.
24. Vandewalle C., Van Roy F., Berx G. The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci 2009, 66:773-787.
25. Pott J., Mahlakoiv T., Mordstein M., Duerr C.U., Michiels T., Stockinger S., et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci USA 2011, 108:7944-7949.
26. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005, 289:G960-8.
27. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
28. Ank N., Iversen M.B., Bartholdy C., Staeheli P., Hartmann R., Jensen U.B., et al. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 2008, 180:2474-2485.
29. Bartlett N.W., Buttigieg K., Kotenko S.V., Smith G.L. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol 2005, 86:1589-1596.
30. Fujita T., Nolan G.P., Ghosh S., Baltimore D. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev 1992, 6:775-787.
31. Ganchi P.A., Sun S.C., Greene W.C., Ballard D.W. A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization. Mol Cell Biol 1993, 13:7826-7835.
32. Zhong H., May M.J., Jimi E., Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002, 9:625-636.
33. Keller A.D., Maniatis T. Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev 1991, 5:868-879.
34. Ren B., Chee K.J., Kim T.H., Maniatis T. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev 1999, 13:125-137.
35. Thanos D., Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 1995, 83:1091-1100.
36. Thanos D., Maniatis T. Identification of the rel family members required for virus induction of the human beta interferon gene. Mol Cell Biol 1995, 15:152-164.
37. Agalioti T., Lomvardas S., Parekh B., Yie J., Maniatis T., Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 2000, 103:667-678.
38. Wang J., Basagoudanavar S.H., Wang X., Hopewell E., Albrecht R., Garcia-Sastre A., et al. NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication. J Immunol 2010, 185:1720-1729.
39. Siren J., Pirhonen J., Julkunen I., Matikainen S. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J Immunol 2005, 174:1932-1937.
40. Matikainen S., Siren J., Tissari J., Veckman V., Pirhonen J., Severa M., et al. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol 2006, 80:3515-3522.
41. Melchjorsen J., Siren J., Julkunen I., Paludan S.R., Matikainen S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J Gen Virol 2006, 87:1099-1108.
42. Wolk K., Witte K., Witte E., Proesch S., Schulze-Tanzil G., Nasilowska K., et al. Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol 2008, 83:1181-1193.
43. Osterlund P., Veckman V., Siren J., Klucher K.M., Hiscott J., Matikainen S., et al. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 2005, 79:9608-9617.
44. Ank N., West H., Bartholdy C., Eriksson K., Thomsen A.R., Paludan S.R. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 2006, 80:4501-4509.
45. Khaitov M.R., Laza-Stanca V., Edwards M.R., Walton R.P., Rohde G., Contoli M., et al. Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 2009, 64:375-386.
46. Mordstein M., Neugebauer E., Ditt V., Jessen B., Rieger T., Falcone V., et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 2010, 84:5670-5677.